Stay updated with breaking news from Anandkumar Nandakumar. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
TherageniX, a University of Nottingham spin out pioneering a dry powder gene therapy formulation for bone graft augmentation, has been awarded a £995,000 grant from Innovate UK.
TherageniX, a University of Nottingham spin out pioneering a dry powder gene therapy formulation for bone graft augmentation, and its collaborator, the University of Nottingham, have been awarded a £995,000 grant from Innovate UK, the UK’s innovation agency. The funding will support the development of the Company’s ...
Funding from Innovate UK’s Transforming Medicines Manufacturing program supporting innovative technologies for intracellular drug delivery.
A gene therapy system that can repair and regenerate human tissue is being developed for use in orthopaedic surgery with the launch of a new spin-out company.TherageniX is a University of Nottingham spin out that’s been launched in collaboration with
University of Nottingham spin out TherageniX, launched in collaboration with healthtech venture builder NLC, is developing technology that uses gene therapy to boost the body’s response to regenerate skin, bone, muscle and cartilage. Click to read more...